Lev’s reporting has explored Americans’ deadly hostility to addiction medications, subpar treatment offered in jails and prisons, shifts in the illicit drug supply and consumption behavior, ...

The prevalence of methamphetamine use in patients presenting with acute coronary syndrome (ACS) was close to 15% in one Northern California medical center, and the drug resulted in significantly ...

Methamphetamine was recently ranked New Zealand's second-most harmful drug behind alcohol, and is the country's most injected drug. Injecting drugs is associated with additional risks such as vein and ...

Methamphetamine (meth) use accounted for nearly 15% of heart attacks for a decade in a northern California study, published today in the Journal of the American Heart Association, an open access, peer ...

WASHINGTON (Reuters) - Methamphetamine use costs the United States about $23.4 billion a year considering lost lives and productivity, drug treatment, law enforcement expenses and other factors, ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

If you or someone you know is struggling with an alcohol, drug or other substance abuse problem, call the free and confidential helpline of the Substance Abuse and Mental Health Services ...

Assessing reduced stimulant use in clinical trials may reveal treatment benefits for cocaine and methamphetamine use disorders.

Two common medications may treat meth addiction effectively when used together But a new study published last month by the Journal of Substance Use and Addiction Treatment looked specifically at the ...

Methamphetamine remains a stubbornly prevalent illicit substance in large swaths of rural America, according to a new study by researchers at Oregon Health & Science University and other institutions.

Methamphetamine, also known as ice or meth, is the drug Australians most associate with a drug problem and the drug they're most concerned about, according to the latest National Drug Strategy ...